DBV Technologies to Engage in September Investor Conferences

DBV Technologies, a late-stage biopharmaceutical firm, has announced its participation in several investor conferences this September. The company is set to feature in the 2026 Cantor Global Healthcare Conference on September 9 with a Fireside Chat at 1:00pm ET, in New York. The next day, it will engage in 1-on-1 Meetings at Citi’s 2026 Biopharma Back to School Conference, also in New York.

Additionally, DBV Technologies will participate in the H.C. Wainwright 28th Annual Global Investment Conference on September 15, with another Fireside Chat scheduled for 3:00pm ET. These sessions can be accessed live via webcasts on the company's website and will remain available for a duration of 90 days post-event.